Detalhe da pesquisa
1.
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Ann Hematol
; 103(1): 105-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036712
2.
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.
Ann Pharmacother
; 56(7): 753-763, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541881
3.
Emerging therapies for AML with myelodysplasia-related changes: slowly but surely moving the needle.
Expert Opin Emerg Drugs
; 26(3): 245-257, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34227451
4.
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia.
Am J Hematol
; 96(4): 462-470, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502020
5.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Blood
; 131(13): 1415-1424, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348128
6.
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes.
Haematologica
; 108(4): 1196-1199, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475522
7.
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.
J Cell Mol Med
; 26(24): 6079-6082, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444394
8.
Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes.
Haematologica
; 101(5): 607-16, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819054
9.
Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemia.
Br J Haematol
; 188(1): 173-177, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621058
10.
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.
Haematologica
; 100(9): 1172-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26022709
11.
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia.
Ann Hematol
; 99(6): 1411-1413, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32377815
12.
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms.
Haematologica
; 99(4): 672-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24362550
13.
Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.
Leuk Lymphoma
; 65(2): 209-218, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921062
14.
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
J Clin Oncol
; 41(15): 2815-2826, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36888930
15.
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
J Clin Oncol
; 41(31): 4893-4904, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703506
16.
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Lancet Haematol
; 10(9): e767-e776, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572683
17.
The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?
Ther Adv Hematol
; 13: 20406207221112899, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35898435
18.
TP53 or Not TP53: That Is the Question.
Clin Cancer Res
; 28(24): 5235-5237, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197410
19.
Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains.
J Geriatr Oncol
; 13(4): 499-504, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955443
20.
Association of QTc Formula With the Clinical Management of Patients With Cancer.
JAMA Oncol
; 8(11): 1616-1623, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136321